Why is there no vaccine for dengue?
The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected.
The value of the vaccine is limited by the fact that it may increase the risk of severe dengue in those who have not previously been infected..
Is there any vaccine for dengue in India?
A limited-use live attenuated dengue vaccine has been licensed since 2015. Two new live attenuated dengue vaccines are currently in phase III efficacy trials. Indian companies have licensed a live attenuated experimental vaccine from the USA.
What happened dengue vaccine?
In late November 2017, the DOH suspended the school-based vaccination program. As of August 2019, over 600 people (mostly children) that had received at least a single dose of the vaccine had died, though not necessarily caused by the vaccine itself.
How long does Dengvaxia last?
Dengvaxia® (also referred to as CYD-TDV), developed by Sanofi Pasteur, is a live recombinant tetravalent dengue vaccine, based on the yellow fever 17D vaccine strain, given as a 3-dose series with 6 months between each dose.